Fenglei Yu

4.0k total citations · 1 hit paper
117 papers, 2.5k citations indexed

About

Fenglei Yu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Fenglei Yu has authored 117 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Pulmonary and Respiratory Medicine, 36 papers in Molecular Biology and 35 papers in Oncology. Recurrent topics in Fenglei Yu's work include Lung Cancer Treatments and Mutations (26 papers), Lung Cancer Diagnosis and Treatment (21 papers) and RNA modifications and cancer (15 papers). Fenglei Yu is often cited by papers focused on Lung Cancer Treatments and Mutations (26 papers), Lung Cancer Diagnosis and Treatment (21 papers) and RNA modifications and cancer (15 papers). Fenglei Yu collaborates with scholars based in China, United States and Saudi Arabia. Fenglei Yu's co-authors include Xiang Wang, Chen Chen, Muyun Peng, Yongguang Tao, Wenliang Liu, Ya Cao, Desheng Xiao, Qin Yan, Yating Liu and Weiwei Lai and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Advanced Functional Materials.

In The Last Decade

Fenglei Yu

104 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA

2019 429 citations Min Wang, Chao Mao et al. Cell Death and Differentiation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fenglei Yu China	27	1.3k	1.0k	961	574	258	117	2.5k
Þórarinn Guðjónsson Iceland	30	1.6k 1.2×	706 0.7×	658 0.7×	1.7k 3.0×	193 0.7×	78	3.4k
Nevins W. Todd United States	32	2.1k 1.6×	1.6k 1.5×	1.5k 1.6×	878 1.5×	614 2.4×	71	4.3k
Nadarajah Vigneswaran United States	26	936 0.7×	516 0.5×	356 0.4×	525 0.9×	222 0.9×	109	2.6k
Takahiro Kimura Japan	31	1.3k 1.0×	811 0.8×	1.7k 1.7×	790 1.4×	390 1.5×	325	4.0k
Sven Peine Germany	26	643 0.5×	535 0.5×	398 0.4×	665 1.2×	491 1.9×	82	2.3k
Martin Eichhorn Germany	31	966 0.7×	316 0.3×	901 0.9×	1.0k 1.8×	245 0.9×	129	3.0k
Takefumi Satoh Japan	33	878 0.7×	441 0.4×	1.6k 1.7×	665 1.2×	266 1.0×	157	3.6k
Alexander Mustea Germany	29	1.3k 1.0×	837 0.8×	241 0.3×	720 1.3×	478 1.9×	146	3.2k
Francesca Bianchi Italy	29	1.6k 1.2×	489 0.5×	244 0.3×	530 0.9×	439 1.7×	96	3.3k

Countries citing papers authored by Fenglei Yu

Since Specialization

Citations

This map shows the geographic impact of Fenglei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fenglei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fenglei Yu more than expected).

Fields of papers citing papers by Fenglei Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fenglei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fenglei Yu. The network helps show where Fenglei Yu may publish in the future.

Co-authorship network of co-authors of Fenglei Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Fenglei Yu. A scholar is included among the top collaborators of Fenglei Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fenglei Yu. Fenglei Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yu, Fenglei, et al.. (2026). Glucagon-like peptide-1 receptor agonists and the risk of nonarteritic anterior ischemic optic neuropathy: Evidence from a global real-world cohort. Diabetes & Metabolism. 52(2). 101740–101740.

Yang, Zhi, Li Wang, Yu He, et al.. (2025). Treatment-related adverse events, immune-related adverse events and discontinuation in patients with solid tumors adding adjuvant immune checkpoint blockade: a meta-analysis of 38 randomized controlled trials. International Journal of Surgery. 111(7). 4756–4771.

Peng, Muyun, et al.. (2025). Mediating role of basophils in the triacylglycerol–asthma link: a Mendelian randomization study. 3 Biotech. 15(9). 303–303.

Peng, Muyun, Xinyi Fan, Bin Wang, et al.. (2025). Deep-learning based electromagnetic navigation system for transthoracic percutaneous puncture of small pulmonary nodules. Scientific Reports. 15(1). 2547–2547.

Yang, Zhi, et al.. (2024). Bidirectional Mendelian Randomization of Causal Relationship between Inflammatory Cytokines and Different Pathological Types of Lung Cancer. Journal of Cancer. 15(15). 4969–4984.

Wei, Yifan, Helong Zhang, Lingzhi Li, et al.. (2024). Sirt1 blocks nucleus pulposus and macrophages crosstalk by inhibiting RelA/Lipocalin 2 axis. Journal of Orthopaedic Translation. 50. 30–43. 2 indexed citations

Xue, He, Fang Wu, Qingchun Liang, et al.. (2024). Confronting synchronous multiple primary lung cancers: Navigating the intersection of challenges and opportunities. Lung Cancer. 197. 107994–107994. 1 indexed citations

Yu, Fenglei, Xiaojie Huang, Zhenyu Zhao, et al.. (2023). Genetic, DNA methylation, and immune profile discrepancies between early-stage single primary lung cancer and synchronous multiple primary lung cancer. Clinical Epigenetics. 15(1). 4–4. 8 indexed citations

Peng, Muyun, et al.. (2023). Mutation of TP53 Confers Ferroptosis Resistance in Lung Cancer Through the FOXM1/MEF2C Axis. American Journal Of Pathology. 193(10). 1587–1602. 10 indexed citations

10.

Song, Xinli, Cheng Wang, Hao He, et al.. (2023). Association of phthalate exposure with pulmonary function in adults: NHANES 2007–2012. Environmental Research. 237(Pt 2). 116902–116902. 5 indexed citations

11.

Hu, Chunhong, Long Shu, Chen Chen, et al.. (2022). A prediction model integrated genomic alterations and immune signatures of tumor immune microenvironment for early recurrence of stage I NSCLC after curative resection. Translational Lung Cancer Research. 11(1). 24–42. 9 indexed citations

12.

Peng, Muyun, Fenglei Yu, Jingqun Tang, et al.. (2021). A novel technique for preoperative localization of pulmonary nodules using a mixture of tissue adhesive and iohexol under computed tomography guidance: A 140 patient single‐center study. Thoracic Cancer. 12(6). 854–863. 6 indexed citations

13.

Peng, Muyun, Qiuyuan Wen, Xia Wu, Fenglei Yu, & Wenliang Liu. (2020). Osimertinib for compound EGFR exon 19 deletion/T790M mutated lung squamous cell carcinoma. Thoracic Cancer. 11(9). 2704–2708. 5 indexed citations

14.

Wang, Min, Chao Mao, Lianlian Ouyang, et al.. (2019). Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA. Cell Death and Differentiation. 26(11). 2329–2343. 429 indexed citations breakdown →

15.

Wang, Bin, et al.. (2019). Three‐dimensional custom‐made carbon‐fiber prosthesis for sternal reconstruction after sarcoma resection. Thoracic Cancer. 10(6). 1500–1502. 8 indexed citations

16.

Wang, Min, Chao Mao, Lianlian Ouyang, et al.. (2019). Correction to: Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA. Cell Death and Differentiation. 27(4). 1447–1447. 26 indexed citations

17.

Wei, Xinru, Yunxin Lai, Jin Li, et al.. (2017). PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells. OncoImmunology. 6(3). e1284722–e1284722. 106 indexed citations

18.

Yu, Fenglei, et al.. (2014). Transient Palsy of Recurrent Laryngeal Nerve Postresection of Giant Substernal Goiter. SHILAP Revista de lepidopterología. 3(1). 51–54. 3 indexed citations

19.

Hu, Wen, et al.. (2012). Large Hemangioma in a Persistent Left Superior Vena Cava. The Thoracic and Cardiovascular Surgeon. 60(S 02). e3–e5. 7 indexed citations

20.

Chen, Long & Fenglei Yu. (2011). [Expression and clinical significance of bromodomain-containing protein 7 in non-small cell lung cancer].. SHILAP Revista de lepidopterología. 14(10). 830–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact